BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4358042)

  • 1. Re-exposure of human lymphoblastoid cell lines to Epstein-Barr virus.
    Diehl V; Wolf H; Schulte-Holthausen H; zur Hausen H
    Int J Cancer; 1972 Nov; 10(3):641-51. PubMed ID: 4358042
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid cell line carrying Epstein-Barr virus.
    Lai PK; Mackay-Scollay EM; Alpers MP
    J Gen Virol; 1973 Oct; 21():135-43. PubMed ID: 4361743
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
    Rocchi G; Hewetson J; Henle W; Henle G
    J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
    Glaser R; Nonoyama M; Decker B; Rapp F
    Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
    [No Abstract]   [Full Text] [Related]  

  • 8. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma.
    Takada M; Murata M; Takei M; Nakagawa S; Okumura H; Kawamura A
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):177-89. PubMed ID: 228891
    [No Abstract]   [Full Text] [Related]  

  • 10. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
    Aya T; Osato T
    Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.
    Miller G; Lisco H; Kohn HI; Stitt D; Enders JF
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1459-65. PubMed ID: 4333101
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
    Schneider U; Schwenk HU; Bornkamm G
    Int J Cancer; 1977 May; 19(5):621-6. PubMed ID: 68013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus: experimental infection of Callithrix jacchus marmosets.
    Falk L; Deinhardt F; Wolfe L; Johnson D; Hilgers J; de-Thé G
    Int J Cancer; 1976 Jun; 17(6):785-8. PubMed ID: 181333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
    Levine PH; Ho JH; Nkrumah F; Andrese AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of Epstein-Barr virus transformed woolly monkey lymphoblastoid cell lines.
    Andiman WA; Miller G
    Proc Soc Exp Biol Med; 1978 Mar; 157(3):489-93. PubMed ID: 204945
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultraviolet inactivation of Epstein--Barr virus-induced nuclear antigen (EBNA), DNA and IgM synthesis in human B lymphocytes.
    Engblom I; Ernberg I
    Virology; 1981 Jul; 112(1):228-39. PubMed ID: 6264682
    [No Abstract]   [Full Text] [Related]  

  • 18. The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line.
    Minowada J; Nonoyama M; Moore GE; Rauch AM; Pagano JS
    Cancer Res; 1974 Aug; 34(8):1898-903. PubMed ID: 4366935
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
    Suzuki M; Hinuma Y
    Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Nonoyama M
    Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.